These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4098771)

  • 1. [Methods for the determination of pathological hyperfibrinolysis of the blood].
    Perlick E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(2):171-85. PubMed ID: 4098771
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endogenous and exogenous fibrinolysis].
    Perlick E; Wilfert K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):28-32. PubMed ID: 4189368
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H
    Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
    [No Abstract]   [Full Text] [Related]  

  • 4. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrin deposition in the ribbit kidney produced by protease inhibitors.
    Beller FK; Mitchell PS; Gorstein F
    Thromb Diath Haemorrh; 1967 May; 17(3-4):427-39. PubMed ID: 5301528
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hyperfibrinolysis as the cause of so-called "spontaneous hemorrhages"].
    Perlick E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):57-63. PubMed ID: 4189373
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo studies on the mechanism of the antifibrinolytic action of E-aminocaproic acid (EACA).
    Lukasiewicz H; Niewiarowski S
    Thromb Diath Haemorrh; 1968 Jul; 19(3):584-92. PubMed ID: 4236825
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of bile salts on some coagulation components and related enzymes.
    Engel AM; Alexander B
    Thromb Diath Haemorrh; 1972 Jul; 27(3):594-609. PubMed ID: 4268053
    [No Abstract]   [Full Text] [Related]  

  • 9. Clearance of infused fibrin.
    Lewis JH; Szeto IL
    Fed Proc; 1965; 24(4):840-5. PubMed ID: 4220570
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fibrinolysis: kinetics of the lysis of a fibrin clot].
    Daver J; Edmond E; Panak E; Ricoeur M
    Rev Eur Etud Clin Biol; 1970 Mar; 15(3):333-42. PubMed ID: 4246032
    [No Abstract]   [Full Text] [Related]  

  • 11. Activity of coagulation and fibrinolytic system components in the vein thrombus.
    Guzowski A; Gacko M; Worowska A; Kowalewski R; Ostapowicz R; Ploński A
    Adv Med Sci; 2006; 51():205-7. PubMed ID: 17357310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
    Thorsen S; Astrup T
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113
    [No Abstract]   [Full Text] [Related]  

  • 13. The action of tick extracts on blood coagulation and fibrinolysis.
    Hellmann K; Hawkins RI
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):617-25. PubMed ID: 5590248
    [No Abstract]   [Full Text] [Related]  

  • 14. The biochemistry of the fibrinolytic enzyme system in man.
    Rickli EE
    Angiologica; 1968; 5(2):66-79. PubMed ID: 4232516
    [No Abstract]   [Full Text] [Related]  

  • 15. 4-aminomethylbicyclo[2.2.2]-octane-1-carboxylic acid a new potent antifibrinolytic agent. Its evaluation by in vitro assay procedures.
    Baumgarten W; Priester LI; Stiller DW; Duncan AE; Ciminera JL; Loeffler LJ
    Thromb Diath Haemorrh; 1969 Nov; 22(2):263-72. PubMed ID: 5380948
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Animal experiment methods for the testing of fibrinolytic and antifibrinolytic agents].
    Klöcking HP; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):84-9. PubMed ID: 4189378
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood coagulation and fibrinolysis in venous blood after prophylactic use of antifibrinolytic agents in heart surgery with the use of xtracorporeal circulation].
    Deutschinoff A; Dimitrov D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):166-73. PubMed ID: 4174654
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperfibrinolysis in cirrhosis.
    Pises P; Bick R; Siegel B
    Am J Gastroenterol; 1973 Sep; 60(3):280-9. PubMed ID: 4126798
    [No Abstract]   [Full Text] [Related]  

  • 20. Review of the biochemistry and coagulation physiology of brinolase. (Fibrinolytic enzyme from Aspergillus oryzae).
    Roschlau WH; Ives DA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):22-37. PubMed ID: 4134481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.